{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:33:59Z","timestamp":1762900439743,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T00:00:00Z","timestamp":1678492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T00:00:00Z","timestamp":1678492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s10072-023-06731-x","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T22:00:32Z","timestamp":1679868032000},"page":"2871-2881","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["IVIg-induced headache: prospective study of a large cohort with neurological disorders"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5740-8822","authenticated-orcid":false,"given":"Buse Rahime","family":"Has\u0131rc\u0131 Bay\u0131r","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mira\u00e7 Ay\u015fen","family":"\u00dcnsal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cansu","family":"A\u011f\u0131rcan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuba","family":"Cerraho\u011flu \u015eirin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onur","family":"Akan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gizem","family":"G\u00fcrsoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tu\u011fba","family":"Eyig\u00fcrb\u00fcz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilara","family":"Mermi Dibek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6n\u00fcl","family":"Akda\u011f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ay\u015fe Deniz","family":"Elmal\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezgi","family":"Nazl\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"Akkoyun Ar\u0131kan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sezin","family":"Alpayd\u0131n Baslo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilek","family":"A\u011f\u0131rcan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emel","family":"Oguz-Akarsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6zdem","family":"Ert\u00fcrk \u00c7etin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T\u00fclin","family":"Geso\u011flu Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esra","family":"Ac\u0131man Demirel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Do\u011fa","family":"Vurall\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u015eule","family":"Deveci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuba","family":"Tanyel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00fcsun","family":"Mayda Doma\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Necdet","family":"Karl\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibel","family":"Velio\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bet\u00fcl","family":"Baykan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayla","family":"\u00c7ulha Oktar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferda","family":"\u0130lgen Uslu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nevra","family":"\u00d6ks\u00fcz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazan","family":"Karag\u00f6z Sakall\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belgin Munise","family":"Mutluay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u0131nar","family":"Bekdik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeynep Vildan","family":"Okudan Atay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,11]]},"reference":[{"issue":"2","key":"6731_CR1","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/ane.12444","volume":"133","author":"S \u017divkovi\u0107","year":"2016","unstructured":"\u017divkovi\u0107 S (2016) Intravenous immunoglobulin in the treatment of neurologic disorders. Acta Neurol Scand 133(2):84\u201396","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"6731_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s13311-015-0391-5","volume":"13","author":"JD L\u00fcnemann","year":"2016","unstructured":"L\u00fcnemann JD, Quast I, Dalakas MC (2016) Efficacy of intravenous immunoglobulin in neurological diseases. Neurotherapeutics 13(1):34\u201346","journal-title":"Neurotherapeutics"},{"key":"6731_CR3","doi-asserted-by":"crossref","unstructured":"Guo Y, Tian X, Wang X, Xiao Z (2018) Adverse effects of immunoglobulin therapy. Front Immunol 9:1299","DOI":"10.3389\/fimmu.2018.01299"},{"issue":"6","key":"6731_CR4","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1177\/1060028015576362","volume":"49","author":"KA Thornby","year":"2015","unstructured":"Thornby KA, Henneman A, Brown DA (2015) Evidence-based strategies to reduce intravenous immunoglobulin-induced headaches. Ann Pharmacother 49(6):715\u2013726","journal-title":"Ann Pharmacother"},{"key":"6731_CR5","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2013). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 33(9):629\u2013808","DOI":"10.1177\/0333102413485658"},{"issue":"5","key":"6731_CR6","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/mus.26678","volume":"60","author":"W Waheed","year":"2019","unstructured":"Waheed W, Ayer GA, Jadoo CL, Badger GJ, Aboukhatwa M, Brannagan TH, Tandan R (2019) Safety of intravenous immune globulin in an outpatient setting for patients with neuromuscular disease. Muscle Nerve 60(5):528\u2013537. https:\/\/doi.org\/10.1002\/mus.26678","journal-title":"Muscle Nerve"},{"key":"6731_CR7","doi-asserted-by":"publisher","unstructured":"Lozeron P, Not A, Theaudin M, Denier C, Masnou P, Sarov M, Adam C, Cauquil C, Adams D (2016). Safety of intravenous immunoglobulin in the elderly treated for a dysimmune neuromuscular disease. Muscle Nerve 53(5):683\u2013689. https:\/\/doi.org\/10.1002\/mus.24942","DOI":"10.1002\/mus.24942"},{"issue":"3","key":"6731_CR8","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/(SICI)1097-4598(199603)19:3<388::AID-MUS20>3.0.CO;2-N","volume":"19","author":"TE Bertorini","year":"1996","unstructured":"Bertorini TE, Nance AM, Horner LH, Greene W, Gelfand MS, Jaster JH (1996) Complications of intravenous gammaglobulin in neuromuscular and other diseases. Muscle Nerve 19(3):388\u2013391. https:\/\/doi.org\/10.1002\/(SICI)1097-4598(199603)19:3%3c388::AID-MUS20%3e3.0.CO;2-N","journal-title":"Muscle Nerve"},{"issue":"3","key":"6731_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.tmrv.2013.05.004","volume":"27","author":"ER Stiehm","year":"2013","unstructured":"Stiehm ER (2013) Side effects of human immunoglobulin therapy. Transfus Med Rev 27(3):171\u2013178","journal-title":"Transfus Med Rev"},{"issue":"6","key":"6731_CR10","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1080\/08916930600825867","volume":"39","author":"U Katz","year":"2006","unstructured":"Katz U, Kishner I, Magalashvili D, Shoenfeld Y, Achiron A (2006) Long term safety of IVIg therapy in multiple sclerosis: 10 years experience. Autoimmunity 39(6):513\u2013517. https:\/\/doi.org\/10.1080\/08916930600825867","journal-title":"Autoimmunity"},{"issue":"6","key":"6731_CR11","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/s12026-018-9047-y","volume":"66","author":"M Lidar","year":"2018","unstructured":"Lidar M, Masarwa S, Rotman P, Carmi O, Rabinowicz N, Levy Y (2018) Intravenous immunoglobulins for rheumatic disorders and thromboembolic events-a case series and review of the literature. Immunol Res 66(6):668\u2013674. https:\/\/doi.org\/10.1007\/s12026-018-9047-y","journal-title":"Immunol Res"},{"issue":"3","key":"6731_CR12","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s10875-010-9373-x","volume":"30","author":"JW Sleasman","year":"2010","unstructured":"Sleasman JW, Duff CM, Dunaway T, Rojavin MA, Stein MR (2010) Tolerability of a new 10% liquid immunoglobulin for intravenous use, Privigen, at different infusion rates. J Clin Immunol 30(3):442\u2013448. https:\/\/doi.org\/10.1007\/s10875-010-9373-x","journal-title":"J Clin Immunol"},{"key":"6731_CR13","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1007\/s13311-021-01108-4","volume":"18","author":"MC Dalakas","year":"2021","unstructured":"Dalakas MC (2021) Update on intravenous immunoglobulin in neurology: modulating neuro-autoimmunity, evolving factors on efficacy and dosing and challenges on stopping chronic IVIg therapy. Neurotherapeutics 18:2397\u20132418","journal-title":"Neurotherapeutics"},{"issue":"1","key":"6731_CR14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12974-021-02229-5","volume":"18","author":"L Biscetti","year":"2021","unstructured":"Biscetti L, De Vanna G, Cresta E, Corbelli I, Gaetani L, Cupini L, Calabresi P, Sarchielli P (2021) Headache and immunological\/autoimmune disorders: a comprehensive review of available epidemiological evidence with insights on potential underlying mechanisms. J Neuroinflammation 18(1):259. https:\/\/doi.org\/10.1186\/s12974-021-02229-5","journal-title":"J Neuroinflammation"},{"key":"6731_CR15","doi-asserted-by":"publisher","unstructured":"Azizi G, Abolhassani H, Asgardoon MH, Shaghaghi S, Negahdari B, Mohammadi J, Rezaei N, Aghamohammadi A (2016) Managing patients with side effects and side events to immunoglobulin therapy. Expert Rev Clin Pharmacol 9(1):91\u2013102. https:\/\/doi.org\/10.1586\/17512433.2016.1105131","DOI":"10.1586\/17512433.2016.1105131"},{"issue":"7","key":"6731_CR16","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1007\/s00415-003-1085-1","volume":"250","author":"M Stangel","year":"2003","unstructured":"Stangel M, Kiefer R, Pette M, Smolka MN, Marx P, Gold R (2003) Side effects of intravenous immunoglobulins in a neurological autoimmune disorders\u2014a prospective study. J Neurol 250(7):818\u2013821. https:\/\/doi.org\/10.1007\/s00415-003-1085-1","journal-title":"J Neurol"},{"issue":"8","key":"6731_CR17","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1136\/adc.2005.078733","volume":"91","author":"D Singh-Grewal","year":"2006","unstructured":"Singh-Grewal D, Kemp A, Wong M (2006) A prospective study of the immediate and delayed side events following intravenous immunoglobulin infusions. Arch Dis Child 91(8):651\u2013654","journal-title":"Arch Dis Child"},{"issue":"11","key":"6731_CR18","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1111\/trf.13200","volume":"55","author":"V Bharath","year":"2015","unstructured":"Bharath V, Eckert K, Kang M, Chin-Yee IH, Hsia CC (2015) Incidence and natural history of intravenous immunoglobulin-induced aseptic meningitis: a retrospective review at a single tertiary care center. Transfusion 55(11):2597\u20132605. https:\/\/doi.org\/10.1111\/trf.13200","journal-title":"Transfusion"},{"issue":"1","key":"6731_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000087720","volume":"54","author":"M Nakajima","year":"2005","unstructured":"Nakajima M (2005) Posterior reversible encephalopathy complicating intravenous immunoglobulins in a patient with the miller-fisher syndrome. Eur Neurol 54(1):58\u201360","journal-title":"Eur Neurol"},{"issue":"1\u20132","key":"6731_CR20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jneuroim.2005.12.001","volume":"173","author":"G Zhang","year":"2006","unstructured":"Zhang G, Lopez PH, Sheikh KA (2006) Comparison of different brands of IVIg in an in vitro model of immune neuropathy. J Neuroimmunol 173(1\u20132):200\u2013203","journal-title":"J Neuroimmunol"},{"issue":"11","key":"6731_CR21","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1007\/s10067-007-0694-y","volume":"26","author":"F Tufan","year":"2007","unstructured":"Tufan F, Kamali S, Erer B, Gul A, Inanc M, Ocal L, Konice M, Aral O (2007) Safety of high-dose intravenous immunoglobulin in systemic autoimmune diseases. Clin Rheumatol 26(11):1913\u20131915. https:\/\/doi.org\/10.1007\/s10067-007-0694-y","journal-title":"Clin Rheumatol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-06731-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-023-06731-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-06731-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T08:14:09Z","timestamp":1689236049000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-023-06731-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,11]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["6731"],"URL":"https:\/\/doi.org\/10.1007\/s10072-023-06731-x","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2023,3,11]]},"assertion":[{"value":"28 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study has ethical approval. Informed consent was obtained from all patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and Informed consent"}}]}}